BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 629993)

  • 1. The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.
    Kahn A; Marie J; Garreau H; Sprengers ED
    Biochim Biophys Acta; 1978 Mar; 523(1):59-74. PubMed ID: 629993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional changes associated with the sequential transformation of L'4 into L4 pyruvate kinase.
    Sprengers ED; Staal GE
    Biochim Biophys Acta; 1979 Oct; 570(2):259-70. PubMed ID: 497228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic control of the pyruvate kinase isozymes in mammals.
    Marie J; Levin MJ; Simon MP; Kahn A
    Isozymes Curr Top Biol Med Res; 1983; 7():221-40. PubMed ID: 6885337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of human erythrocyte pyruvate kinase by soluble cyclic-AMP-dependent protein kinases. Comparison with human liver L-type enzyme.
    Marie J; Buc H; Simon MP; Kahn A
    Eur J Biochem; 1980; 108(1):251-60. PubMed ID: 6250830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.
    Wang C; Chiarelli LR; Bianchi P; Abraham DJ; Galizzi A; Mattevi A; Zanella A; Valentini G
    Blood; 2001 Nov; 98(10):3113-20. PubMed ID: 11698298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of human red cell and liver pyruvate kinase. Differences between liver and erythrocyte L-type subunits.
    Boivin P; Galand C; Estrada M
    Experientia; 1980 Aug; 36(8):900-1. PubMed ID: 7439324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative kinetic behaviour and regulation by fructose-1,6-bisphosphate and ATP of pyruvate kinase from erythrocytes, reticulocytes and bone marrow cells.
    Rodriguez-Horche P; Luque J; Perez-Artes E; Pineda M; Pinilla M
    Comp Biochem Physiol B; 1987; 87(3):553-7. PubMed ID: 3621913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate kinase isozymes in man. II. L type and erythrocyte-type isozymes. Electrofocusing and immunologic studies.
    Kahn A; Marie J; Boivin P
    Hum Genet; 1976 Jul; 33(1):35-46. PubMed ID: 820628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the rat L-type pyruvate kinase gene from its dual erythroid- and liver-specific promoter in transgenic mice.
    Tremp GL; Boquet D; Ripoche MA; Cognet M; Lone YC; Jami J; Kahn A; Daegelen D
    J Biol Chem; 1989 Nov; 264(33):19904-10. PubMed ID: 2584201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of three mutant isozymes of erythrocyte pyruvate kinase: PK-"Gainesville," PK-"San Juan," and PK-"Cape Canaveral".
    Paglia DE; Keitt AS; Valentine WN; Gordon S
    Am J Hematol; 1983 Jun; 14(4):335-44. PubMed ID: 6859032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki.
    Nakashima K; Miwa S; Fujii H; Shinohara K; Yamauchi K; Tsuji Y; Yanai M
    J Lab Clin Med; 1977 Dec; 90(6):1012-20. PubMed ID: 925478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular organization of human L' and L pyruvate kinases.
    Simon MP; Marie J; Bertrand O; Kahn A
    Biochim Biophys Acta; 1982 Dec; 709(1):1-7. PubMed ID: 6758852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of human M2-type pyruvate kinases isolated from human leukocytes and erythrocytes of a patient with red cell pyruvate kinase hyperactivity.
    Kechemir D; Max-Audit I; Rosa R
    Enzyme; 1989; 41(3):121-30. PubMed ID: 2498076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic properties of pyruvate kinase hybrids formed with native type L and inactivated type M subunits.
    Hubbard DR; Cardenas JM
    J Biol Chem; 1975 Jul; 250(13):4931-6. PubMed ID: 1171094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step purification of L-type pyruvate kinase by microimmunoaffinity chromatography.
    Nürnberg P; Jacobasch G; Noll F; Thiele B
    Biomed Biochim Acta; 1983; 42(11-12):S283-6. PubMed ID: 6675703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-type pyruvate kinase from human liver. Purification by double affinity elution, electrofocusing and immunological studies.
    Marie J; Kahn A; Boivin P
    Biochim Biophys Acta; 1976 Jul; 438(2):393-406. PubMed ID: 821529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An allele (Pk-1b) from wild-caught mice that affects the activity and kinetics of erythrocyte and liver pyruvate kinase.
    Moore KJ; Bulfield G
    Biochem Genet; 1981 Aug; 19(7-8):771-81. PubMed ID: 7295298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monomeric form of pyruvate kinase in human pyruvate kinase deficiency.
    Adachi K; Ghory PK; Asakura T; Schwartz E
    Proc Natl Acad Sci U S A; 1977 Feb; 74(2):501-4. PubMed ID: 15247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate kinase isozymes in cells isolated from fetal and regenerating rat liver.
    Dyson RD; Cardenas JM; Richards TC; Garnett ME
    Biochim Biophys Acta; 1977 Mar; 481(1):115-26. PubMed ID: 843536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.